Venn Life Sciences (LON:VENN) Share Price Crosses Above 50-Day Moving Average – Here’s What Happened

Venn Life Sciences Holdings PLC (LON:VENNGet Free Report) passed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of GBX 6.85 ($0.09) and traded as high as GBX 7 ($0.09). Venn Life Sciences shares last traded at GBX 6.85 ($0.09), with a volume of 1,027,544 shares trading hands.

Venn Life Sciences Trading Up 7.0 %

The company has a debt-to-equity ratio of 35.83, a current ratio of 2.30 and a quick ratio of 1.48. The company has a market capitalization of £4.89 million and a price-to-earnings ratio of -2.14. The business’s 50 day simple moving average is GBX 6.85 and its 200 day simple moving average is GBX 6.85.

Venn Life Sciences Company Profile

(Get Free Report)

Venn Life Sciences Holdings Plc, a clinical research organization, provides consulting and clinical trial services to pharmaceutical, biotechnology, and medical device companies in the United Kingdom, Ireland, France, the Netherlands, Germany, and Singapore. The company offers drug development planning and strategy services, including clinical feasibility assessment, project management, and in-licensing and technical due diligence; and early drug development services, such as drug candidate selection, CMC, non-clinical/pre-clinical development, clinical pharmacology, pharmacokinetics, and pharmacometrics and PK-PD modelling.

Featured Articles

Receive News & Ratings for Venn Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Venn Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.